Home/Filings/4/0001290929-23-000008
4//SEC Filing

Wolf James G. 4

Accession 0001290929-23-000008

CIK 0000316253other

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 9:41 PM ET

Size

19.2 KB

Accession

0001290929-23-000008

Insider Transaction Report

Form 4
Period: 2023-02-10
Wolf James G.
10% Owner
Transactions
  • Purchase

    Common Stock, $0.01 par value

    2023-02-10$1.29/sh+5,000$6,4504,095,000 total
  • Purchase

    Common Stock, $0.01 par value

    2023-02-13$1.28/sh+5,000$6,4254,100,000 total
  • Purchase

    Common Stock, $0.01 par value

    2023-02-13$1.29/sh+5,000$6,450115,000 total(indirect: See Footnote)
  • Sale

    Long Call Option (right to buy)

    2023-02-13$0.19/sh324$62483 total
    Exercise: $5.00From: 2022-10-28Exp: 2023-04-21Common Stock, $0.01 par value (32,400 underlying)
  • Sale

    Short Put Option (obligation to buy)

    2023-02-13$1.01/sh+324$327324 total
    Exercise: $2.50From: 2023-02-13Exp: 2023-07-21Common Stock, $0.01 par value (32,400 underlying)
  • Sale

    Short Put Option (obligation to buy)

    2023-02-13$0.03/sh750$230 total
    Exercise: $7.50From: 2022-10-28Exp: 2023-04-21Common Stock, $0.01 par value (75,000 underlying)
  • Sale

    Short Put Option (obligation to buy)

    2023-02-13$1.12/sh+750$8402,163 total
    Exercise: $2.50From: 2023-02-13Exp: 2023-04-21Common Stock, $0.01 par value (75,000 underlying)
Holdings
  • Common Stock, $0.01 par value

    (indirect: See Footnote)
    308,500
  • Long Call Option (right to buy)

    Exercise: $2.50From: 2022-10-28Exp: 2023-04-21Common Stock, $0.01 par value (100,000 underlying)
    1,000
Footnotes (2)
  • [F1]The transaction was completed in the name and for the benefit of the Reporting Person's sibling. The Reporting Person maintains a power of attorney granted by the Reporting Person's sibling with respect to these shares, including voting and dispositive power over the shares. The Reporting Person has no pecuniary interest in the shares and disclaims beneficial ownership of the securities held by his sibling. This report will not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
  • [F2]The 308,500 shares owned indirectly by the Reporting Person include 116,000 shares held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person, 22,000 shares held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person's spouse and 170,500 shares owned directly by adult children of the Reporting Person.

Issuer

ENZO BIOCHEM INC

CIK 0000316253

Entity typeother

Related Parties

1
  • filerCIK 0001419248

Filing Metadata

Form type
4
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 9:41 PM ET
Size
19.2 KB